Amendment: SEC Form SCHEDULE 13G/A filed by BlackRock Inc.
SCHEDULE 13G/A - BlackRock, Inc. (0002012383) (Filed by)
Live Feed
Delayed 3mPress · Analyst · Buys · SEC · Leadership Updates
Signed out · 3-min delay · Sign up for real-time
- SEC Form 425 filed by Live Oak Acquisition Corp. V
425 - Live Oak Acquisition Corp. V (0002048951) (Subject)
- SEC Form DEF 14A filed by Disc Medicine Inc.
DEF 14A - Disc Medicine, Inc. (0001816736) (Filer)
- Orange County Bancorp Inc. filed SEC Form 8-K: Financial Statements and Exhibits
8-K - Orange County Bancorp, Inc. /DE/ (0001754226) (Filer)
- SEC Form 10-Q filed by General Motors Company
10-Q - General Motors Co (0001467858) (Filer)
- SEC Form DEFA14A filed by Neuraxis Inc.
DEFA14A - Neuraxis, INC (0001933567) (Filer)
- SEC Form DEF 14A filed by Xilio Therapeutics Inc.
DEF 14A - Xilio Therapeutics, Inc. (0001840233) (Filer)
- Janux Therapeutics Inc. filed SEC Form 8-K: Leadership Update
8-K - Janux Therapeutics, Inc. (0001817713) (Filer)
- SEC Form 10-Q filed by NeoGenomics Inc.
10-Q - NEOGENOMICS INC (0001077183) (Filer)
- SEC Form S-3ASR filed by BitMine Immersion Technologies Inc.
S-3ASR - BITMINE IMMERSION TECHNOLOGIES, INC. (0001829311) (Filer)
- SEC Form DEF 14A filed by Hepion Pharmaceuticals Inc.
DEF 14A - Hepion Pharmaceuticals, Inc. (0001583771) (Filer)
- Chief Financial Officer Gray James D bought $199,781 worth of shares (4,556 units at $43.85), increasing direct ownership by 8% to 59,741 units (SEC Form 4)
4 - Lamb Weston Holdings, Inc. (0001679273) (Issuer)
- SEC Form FWP filed by Toronto Dominion Bank
FWP - TORONTO DOMINION BANK (0000947263) (Subject)
- SEC Form DEF 14A filed by Iovance Biotherapeutics Inc.
DEF 14A - IOVANCE BIOTHERAPEUTICS, INC. (0001425205) (Filer)
- SEC Form 20-F filed by Newegg Commerce Inc.
20-F - Newegg Commerce, Inc. (0001474627) (Filer)
- SEC Form DEFA14A filed by lululemon athletica inc.
DEFA14A - lululemon athletica inc. (0001397187) (Filer)
- First Busey Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
8-K - FIRST BUSEY CORP /NV/ (0000314489) (Filer)
- Mainz Biomed N.V. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
8-K - Quantum Cyber N.V. (0001874252) (Filer)
- Amendment: Live Oak Acquisition Corp. V filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
8-K/A - Live Oak Acquisition Corp. V (0002048951) (Filer)